MRI Interventions announces Joseph Burnett as new president, CEO

MRI Interventions announced in an Oct. 9 release that Joseph Burnett as its new president and CEO, effective Nov. 7. According to a press release from Global Newswire, MRI Interventions’ current president, Frank Grillo, will continue in the role until Nov. 6 and for a period of time after will serve as the company’s executive advisor. Grillo has served as president and CEO for MRI Interventions for the last three years.

“We are excited to announce Joe Burnett as the new CEO of MRI Interventions. Joe is a strong leader with unique and highly relevant qualifications in the medical device industry and neurology,” said Kimble Jenkins, MRI Interventions Chairman of the Board of Directors, in the company’s press release. “With his experience and expertise, Joe is ideally suited to lead the company’s next phase of growth, building on the strong foundation established over the last three years under Frank’s leadership.”

Burnett started his career working in the cardiovascular department at Guidant and Volcano. Most recently, he worked in Neurology and Neurosurgery at Philips, serving as the vice president and general manager. Other important operational responsibilities held throughout his career include R&D, clinical research, sales and marketing.

“I am thrilled to join the MRI team and help lead this next chapter which will focus on clinical development, market adoption and continued procedure growth,” said Burnett in the press release.

Burnett has an impressive track record with his entire career focused in medical devices. He holds a B.S.E. in Biomedical Engineering from Duke University and an MBA from the Duke’s Fuqua Business School.

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.